New staging system of the fifth Joint National Committee Report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension

Hypertension

Volumn 28, Issue 5, 1996, Pages 713-718

  Pogue, Velvie Anne ^a,b   Ellis, Charlotte ^a   Michel, Julienne ^a   Francis, Charles K ^a  

^a The New York Presbyterian Hospital   (United States)

^b HARLEM HOSPITAL CENTER   (United States)

Author keywords

blacks; blood pressure classification; meeting report (Joint National Committee)

Indexed keywords

ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK; STAGING; SYSTOLIC BLOOD PRESSURE;

EID: 0029908402     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.5.713     Document Type: Article

References (14)

1. Joint National Committee. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1993;153:154-183.
2. Black HR. Treatment of mild hypertension: the more things change. JAMA. 1993;270:757-759. Editorial.
3. Joint National Committee. Report on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1980;140: 1280-1285.
4. Joint National Committee. Report on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1984;144: 1045-1057.
5. Joint National Committee. 1988 Report of the JNC on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1988;148:1023-1038.
6. Moser J, Herbert P, Hennekens CH. An overview of the meta-analysis of the hypertension treatment trials. Arch Intern Med. 1991; 151:1277-1279.
7. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, Part 2: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
8. Kannel WB, Gordon T. Evaluation of cardiovascular risk factors in the elderly: the Framingham study. Bull N Y Acad Med. 1978;54:573-591.
9. Abernethy J, Borhani NO, Hawkins CM, Crow R, Entwisle G, Jones JW, Maxwell MH, Langford H, Pressel S. Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow up Program. Am J Prev Med. 1986;2:123-132.
10. Hypertension Detection and Follow-up Program Cooperative Group. Race, education, and prevalence of hypertension. Am J Epidemiol. 1977;106:351.
11. Hammond IW, Devereaux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986;7: 639-650.
12. Prineas RJ, Castle CH, Curb JD, Harrist K, Lewin A, Stamler J. Baseline electrocardiographic characteristics of the hypertensive participants. In: Dougherty SA, Entwisle G, eds. Hypertension Detection and Follow-up Program: Baseline characteristics of the enumerated, screened, and hypertensive participants. Hypertension. 1983;5(suppl IV):IV-160-IV-189.
13. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med. 1989; 320:684-688.
14. Smith WM, Bagniewska A, Furberg CD, Kuller L, Perry HM, Schnaper HW. Blood pressure characteristics of a population aged 60 to 90 years: SHEP. J Hypertens. 1986;4(suppl 5):S564. Abstract.